Corpus Intelligence IC Memo — IU HEALTH JAY HOSPITAL 2026-04-26 18:05 UTC
IC Memo — IU HEALTH JAY HOSPITAL
Investment Committee Memorandum | IN | 21 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

IU HEALTH JAY HOSPITAL

CCN 151320 | JAY, IN | 21 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

IU HEALTH JAY HOSPITAL is a 21-bed rural/critical access in JAY, IN with $38.8M in net patient revenue and a -5.6% operating margin. The hospital serves a payer mix of 44.4% Medicare, 0.9% Medicaid, and 54.7% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.6% to 1.8% (+736bps).

Net Revenue HCRIS$38.8M
Current EBITDA COMPUTED$-2.2M
Operating Margin COMPUTED-5.6%
Occupancy HCRIS24.7%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS45.3%
Distress Probability ML54.4%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
73
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -5.6% places it below the state median. Among 73 size-comparable peers (10-42 beds), the median margin is -5.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-42), prioritizing same-state peers. 73 hospitals in the comp set.

HospitalStateBedsRevenueMargin
IU HEALTH JAY HOSPITAL (Target)IN21$38.8M-5.6%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
MEMORIAL HOSPITAL LOGANSPORTIN37$103.6M-17.4%
CAMERON MEMORIAL COMMUNITY HOSIN25$95.1M7.4%
THE OTIS R. BOWEN CENTERIN20$92.4M-11.2%
WHITLEY MEMORIAL HOSPITALIN30$87.8M1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$815K+210bp18mo
Cost to Collect4.5%2.5%$777K+200bp12mo
Denial Rate Reduction12.0%6.5%$769K+198bp12mo
A/R Days Reduction5200.0%3800.0%$473K+122bp9mo
Clean Claim Rate88.0%96.0%$25K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$815K
Cost to Collect
$777K
Denial Rate Reduction
$769K
A/R Days Reduction
$473K
Clean Claim Rate
$25K
Total EBITDA Uplift$2.9M
Current EBITDA$-2.2M
+ RCM Uplift+$2.9M
Pro Forma EBITDA$696K
Current Margin-5.6%
Pro Forma Margin1.8%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.3M$14.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.3M$14.7M0.00x-100.0%
Bull Case9.0x11.0x$-3.0M$23.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.0M$24.2M0.00x-100.0%
Bear Case11.0x10.0x$-3.7M$1.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.7M$31K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 24.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 73 hospitals with 10-42 beds
  • Same-state prioritization (n=74)
  • Comp margins: P25=-17.8% / P50=-5.5% / P75=5.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.